Fabio Lugoboni

2.1k total citations
99 papers, 1.4k citations indexed

About

Fabio Lugoboni is a scholar working on Epidemiology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, Fabio Lugoboni has authored 99 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 29 papers in Psychiatry and Mental health and 20 papers in Experimental and Cognitive Psychology. Recurrent topics in Fabio Lugoboni's work include Attention Deficit Hyperactivity Disorder (16 papers), Hepatitis C virus research (16 papers) and Hepatitis B Virus Studies (14 papers). Fabio Lugoboni is often cited by papers focused on Attention Deficit Hyperactivity Disorder (16 papers), Hepatitis C virus research (16 papers) and Hepatitis B Virus Studies (14 papers). Fabio Lugoboni collaborates with scholars based in Italy, United States and Spain. Fabio Lugoboni's co-authors include Gianluca Quaglio, Paolo Mezzelani, Alessandro Lechi, Rebecca Casari, Don C. Des Jarlais, Lorenzo Zamboni, Marco Faccini, Stefano Tamburin, G. Talamini and Angela Federico and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Fabio Lugoboni

96 papers receiving 1.4k citations

Peers

Fabio Lugoboni
Joan E. Zweben United States
Steven L. Batki United States
Julia Shi United States
Charles Moore United States
Otto Lesch Austria
Lucy Thi Tran Australia
Uwe Verthein Germany
Raye Z. Litten United States
Joan E. Zweben United States
Fabio Lugoboni
Citations per year, relative to Fabio Lugoboni Fabio Lugoboni (= 1×) peers Joan E. Zweben

Countries citing papers authored by Fabio Lugoboni

Since Specialization
Citations

This map shows the geographic impact of Fabio Lugoboni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Lugoboni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Lugoboni more than expected).

Fields of papers citing papers by Fabio Lugoboni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Lugoboni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Lugoboni. The network helps show where Fabio Lugoboni may publish in the future.

Co-authorship network of co-authors of Fabio Lugoboni

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Lugoboni. A scholar is included among the top collaborators of Fabio Lugoboni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Lugoboni. Fabio Lugoboni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sofia, Carlos, et al.. (2025). Cytisine for smoking cessation in hospitalised smokers with cardiovascular diseases: an observational study. Internal and Emergency Medicine. 20(3). 817–828. 2 indexed citations
2.
Zamboni, Lorenzo, Igor Portoghese, Rebecca Casari, et al.. (2024). High-dose benzodiazepine use and QTc interval prolongation, a latent class analysis study. Scientific Reports. 14(1). 155–155. 1 indexed citations
3.
Casari, Rebecca, et al.. (2024). Safety and efficacy of CyTisine for smoking cessation in a hOSPital context (CITOSP): study protocol for a prospective observational study. Frontiers in Public Health. 12. 1350176–1350176. 2 indexed citations
4.
Zamboni, Lorenzo, et al.. (2024). An example of cytisine overdose with no consequent side-effects: a case report. Journal of Medical Case Reports. 18(1). 578–578.
5.
Perlini, Cinzia, Valeria Donisi, Anna Mason, et al.. (2023). “INTEGRO INTEGRated Psychotherapeutic InterventiOn” on the Management of Chronic Pain in Patients with Fibromyalgia: The Role of the Therapeutic Relationship. International Journal of Environmental Research and Public Health. 20(5). 3973–3973. 5 indexed citations
6.
Casari, Rebecca, et al.. (2022). Cytisine induced urticaria : a case report during a smoking cessation treatment.. PubMed. 93(S1). e2022073–e2022073. 2 indexed citations
7.
Zamboni, Lorenzo, et al.. (2022). Case Report: High doses of Zolpidem and QT interval lengthening: Is there a relationship? A case series. Frontiers in Psychiatry. 13. 1033061–1033061. 2 indexed citations
8.
Zamboni, Lorenzo, Rebecca Casari, Elisa Tedeschi, et al.. (2022). A virtual reality craving study in tobacco addiction: The role of non-pharmacological support in tobacco detox therapy. Frontiers in Psychiatry. 13. 940100–940100. 1 indexed citations
9.
Alvaro, Domenico, Flaminia Coluzzi, Walter Gianni, et al.. (2022). Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later. Pain and Therapy. 11(2). 477–491. 8 indexed citations
10.
Zamboni, Lorenzo, et al.. (2022). Study protocol—Evoked craving in high-dose benzodiazepine users. Frontiers in Psychiatry. 13. 956892–956892. 1 indexed citations
11.
Federico, Angela, Fabio Lugoboni, Elisa Mantovani, et al.. (2020). Detoxification Improves Multidomain Cognitive Dysfunction in High-Dose Benzodiazepine Abusers. Frontiers in Neuroscience. 14. 747–747. 5 indexed citations
12.
Faccini, Marco, et al.. (2019). High-dose lormetazepam dependence: strange case of Dr. Jekyll and Mr. Hyde. Internal and Emergency Medicine. 14(8). 1271–1278. 15 indexed citations
13.
Libera, Chiara Della, Thomas Zandonai, Lorenzo Zamboni, et al.. (2019). Revealing Dissociable Attention Biases in Chronic Smokers Through an Individual-Differences Approach. Scientific Reports. 9(1). 4930–4930. 5 indexed citations
14.
Lugoboni, Fabio, Antonio Mirijello, Marco Faccini, et al.. (2014). Quality of life in a cohort of high-dose benzodiazepine dependent patients. Drug and Alcohol Dependence. 142. 105–109. 49 indexed citations
15.
Quaglio, Gianluca, Cristian Pattaro, Gilberto Gerra, et al.. (2012). High dose benzodiazepine dependence: Description of 29 patients treated with flumazenil infusion and stabilised with clonazepam. Psychiatry Research. 198(3). 457–462. 34 indexed citations
16.
Quaglio, Gianluca, et al.. (2008). Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug and Alcohol Dependence. 94(1-3). 12–18. 72 indexed citations
17.
Lugoboni, Fabio, et al.. (2007). Association between depressive mood and cigarette smoking in a large Italian sample of smokers intending to quit: implications for treatment. Internal and Emergency Medicine. 2(3). 196–201. 9 indexed citations
18.
Quaglio, Gianluca, Fabio Lugoboni, Cristian Pattaro, et al.. (2006). Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients. BMC Public Health. 6(1). 216–216. 13 indexed citations
19.
Choquet, Marie, Philippe Arvers, Patrick Peretti‐Watel, et al.. (2002). Managerial considerations in implementing hepatitis b vaccination programs among drug‐using cohorts: response to Awofesor. Addiction. 97(12). 1613–1614. 2 indexed citations
20.
Lugoboni, Fabio, et al.. (1997). Immunoresponse to hepatitis B vaccination and adherence campaign among injecting drug users. Vaccine. 15(9). 1014–1016. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026